FLT3 and acute myeloid leukemia: Moreover, derivative 61 exhibited notable anti-proliferative effects against FLT3-ITD-, FLT3-ITDF691L-, and FLT3-ITD D835Y-driven AML cell lines, with IC50 levels 0.16, 1.29, and 1.50 μM, respectively (Figure 34).